Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype.
about
Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantationShould eligible patients with T-cell lymphoma receive high-dose therapy and autologous stem cell transplant in the upfront setting?Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience.Autologous stem cell transplantation as the first-line treatment for peripheral T cell lymphoma: results of a comprehensive meta-analysis.Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey.The role of allogeneic transplantation in non-Hodgkin's lymphoma.Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma.Hematopoietic stem cell transplantation in peripheral T-cell lymphomas.Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.Controversies in the treatment of lymphoma with autologous transplantation.Stem cell transplantation as a biological therapy for peripheral T-cell lymphomas.Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).Treatment algorithms for mature T-cell and natural killer-cell neoplasms.Novel treatment avenues for peripheral T-cell lymphomas.Successful treatment of small cell variant anaplastic large cell lymphoma with allogeneic peripheral blood stem cell transplantation, and review of the literature.Current state of art for transplantation paradigms in peripheral T-cell lymphomas.Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease.Impact of autologous and allogeneic stem cell transplantation in peripheral T-cell lymphomas.ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma.IMVP-16/Pd followed by high-dose chemotherapy and autologous stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell lymphomas.Treatment response and overall outcome of patients with relapsed and refractory peripheral T-cell lymphoma compared to diffuse large B-cell lymphoma.Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study.High-dose therapy and autologous stem cell transplantation in Korean patients with aggressive T/NK-cell lymphoma.
P2860
Q28254421-DC61AE26-7AC2-4442-B66E-7B1F599C6E3BQ33822764-277811FE-C02D-436B-BC66-B1CC6C0A77F4Q34307446-821B5183-831E-46F5-B202-3B45A5288BC8Q35025993-00F258C7-9208-46A8-9797-0D0A97D0A586Q35608203-116CD39D-1B92-45A9-AD26-A78ED2FD80DCQ36003103-777477CD-F93B-4889-8958-29A0E28B1463Q36499270-8C8D7050-6DEC-498F-AAD7-196590F7D19DQ36911495-E6B13667-8E68-4596-9564-6566C5CA9B98Q37122302-E055D1AD-DA68-4BDC-B274-08E8D8A96BE6Q37593800-C804C468-3F27-416B-B7E4-A264B15CDD1DQ37809085-A7C71EF9-3814-47F0-9234-4FD6EA980450Q37863688-618F21E3-D5BF-414A-A813-A7E2BF75BF62Q37932546-053E58E9-2665-4133-B25F-FAEAE65ECCAFQ38045460-AA273858-DBC8-4FA5-A330-7D14E53682C8Q38069537-5DF9E73F-DF08-4D68-8294-20ABD92FE4C0Q38132821-B562CBAB-964A-48A8-B71F-06AA2789183FQ38207137-635E8A59-9F8A-4774-88AA-6935CCFA6F54Q41928592-DE14358B-B387-41EF-A953-A32EE6150069Q45124918-51521428-4538-4502-AD13-6192F6539933Q46786373-57CD8542-C913-476F-989C-B06C0590870BQ47256653-77B5CA12-9C29-47FA-88C9-159462108465Q48650246-F2A4239E-D0A0-46FB-AC1B-AA3461D6C6FFQ53263173-2FCC59A6-CB47-410C-9B84-AAA2D723D293
P2860
Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Autologous stem cell transplan ...... rding to pathological subtype.
@en
Autologous stem cell transplan ...... rding to pathological subtype.
@nl
type
label
Autologous stem cell transplan ...... rding to pathological subtype.
@en
Autologous stem cell transplan ...... rding to pathological subtype.
@nl
prefLabel
Autologous stem cell transplan ...... rding to pathological subtype.
@en
Autologous stem cell transplan ...... rding to pathological subtype.
@nl
P2093
P2860
P1476
Autologous stem cell transplan ...... rding to pathological subtype.
@en
P2093
Armand Keating
Kevin W Song
Michael Crump
Peter Mollee
P2860
P304
P356
10.1046/J.1365-2141.2003.04203.X
P407
P577
2003-03-01T00:00:00Z